<DOC>
	<DOCNO>NCT02953054</DOCNO>
	<brief_summary>The purpose study evaluate whether DMTS , compare placebo patch , provide adequate pain relief first 3 day follow bunionectomy surgery .</brief_summary>
	<brief_title>DMTS Post-Operative Analgesia Following Bunionectomy</brief_title>
	<detailed_description>The primary objective study evaluate analgesic efficacy DMTS , compare placebo subject acute moderate severe pain follow unilateral bunionectomy . The secondary objective : - To assess safety tolerability DMTS , include assessment skin irritation - To assess adhesion DMTS - To assess sedation effect DMTS</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . Voluntarily provide write informed consent . 2 . Male female , â‰¥ 18 year age . 3 . Scheduled undergo primary unilateral first metatarsal bunionectomy repair . 4 . Have physical status classification 1 2 per American Society Anesthesiology . 5 . Nonsmoker least 1 year prior screening ; nonsmoking define cessation smoking use tobacco nicotine product ( include chew tobacco , snuff , ecigarettes , nicotine patch , etc. ) . 6 . Female subject eligible follow apply : 1 . Not pregnant , lactating , plan become pregnant study 2 . Surgically sterile ; least 2 year postmenopausal ; monogamous partner surgically sterile ; gender sex partner ; practice doublebarrier contraception ; practice abstinence ; use insertable , injectable , transdermal , combination oral contraceptive 7 . Male subject female sex partner must surgically sterile commit use reliable method birth control . 8 . Have body weight &gt; 50 kg , body mass index 22 38 kg/m2 , inclusive . 9 . Able understand study procedure , comply study procedure , agree participate study program full duration . 1 . Have know sensitivity excipients DMTS/placebo peri postoperative medication use study . 2 . Have skin abnormality ( eg , scar , tattoo ) unhealthy skin condition ( eg , burn , wound ) patch application site , accord examination investigator screen admission clinic prior surgery . 3 . Have clinically significant abnormal clinical laboratory test value . 4 . Have history positive test result human immunodeficiency virus ( HIV ) , hepatitis B , hepatitis C. 5 . Have history clinical manifestation : significant renal , hepatic , cardiovascular , metabolic , neurologic , psychiatric condition ; congestive heart failure , peptic ulcer , gastrointestinal bleeding , condition would preclude participation study . 6 . Have history migraine frequent headache , seizure , currently take anticonvulsant . 7 . Have another painful physical condition may confound assessment postoperative pain . 8 . Have history syncope syncopal attack . 9 . Have evidence clinically significant 12lead ECG abnormality . 10 . Have history alcohol abuse prescription/illicit drug abuse . 11 . Have positive result urine drug screen alcohol breath test indicative illicit drug alcohol use screen and/or day surgery . 12 . Have history evidence orthostatic hypotension . 13 . Have rest heart rate &lt; 50 beat per minute systolic blood pressure &lt; 100 mmHg . 14 . Have receive receive opioid therapy chronically &gt; 2 week within month prior dose study drug . 15 . Use concurrent therapy could interfere evaluation efficacy safety , drug investigator 's opinion may exert significant analgesic property act synergistically dexmedetomidine . 16 . Have upper respiratory tract infection within 14 day prior dose study drug . 17 . Have utilized oral injectable corticosteroid within 14 day prior dose study drug ( intranasal topical corticosteroid use time period allow ) . 18 . Have receive investigational product within 30 day prior dose study drug . 19 . Have previously receive DMTS clinical trial . 20 . Sensitivity opioids , nonsteroidal antiinflammatory drug , antibiotic . 21 . In opinion investigator designee , consider unsuitable study entry and/or unlikely comply study protocol reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pain</keyword>
	<keyword>Bunionectomy</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Transdermal</keyword>
	<keyword>Patch</keyword>
	<keyword>Postoperative</keyword>
	<keyword>DMTS</keyword>
</DOC>